Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P00750 (
PLA
)
16,800
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Lysozyme, alpha-amylase, neutral proteinase and
plasminogen activator
were most concentrated in the initial portion of the ejaculate that consists mostly of Cowper's gland and prostate gland fluids as well as
spermatozoa
. The concentration of the high molecular weight proteinase inhibitors, alpha1-antitrypsin and alpha1X-antichymotrypsin, was essentially unaltered throughout the ejaculate fractions, although their absolute amounts showed an increase towards the final fraction. By contrast, the total inhibitory activity towards pancreatic trypsin was highest both in concentration and amount in the last fraction, thus indicating that the seminal vesicles are its primary source. Plasminogen, prothrombin, Factor XIII, and the proteinase inhibitors antithrombin III, alpha2-macroglobulin, inter-alpha-trypsin inhibitor and C1S-inactivator could not be detected immunochemically in whole ejaculates, and indicates the dissimilarity between the coagulation/liquefaction processes of semen and blood.
...
PMID:Components of human split ejaculates. II. Enzymes and proteinase inhibitors. 108 6
We have recently shown that
spermatozoa
of various species contain both types of
plasminogen activator
, the tissue-type (t-PA) and the urokinase-type (u-PA). In the present study, the localization of t-PA and u-PA in plasma membrane and outer acrosomal membrane of human and boar
spermatozoa
has been investigated. The identification of the type of the
plasminogen activator
(t-PA or u-PA) was made immunologically. In human
spermatozoa
, the outer acrosomal membrane and plasma membrane contained both types of
plasminogen activator
(t-PA and u-PA); in addition, t-PA antigen was measured. In boar
spermatozoa
, the outer acrosomal membrane contained only t-PA, whereas plasma membrane contained both types of
plasminogen activator
(t-PA and u-PA). Plasminogen activator inhibition (PAI) has also been demonstrated in plasma and outer acrosomal membranes of both species and identified as PAI-1 in membranes of human
spermatozoa
.
...
PMID:Plasminogen activator: the identification of an additional proteinase at the outer acrosomal membrane of human and boar spermatozoa. 135 44
The resumption of meiosis results in synthesis of
tissue-type plasminogen activator
(tPA) in the rat and mouse oocytes (Haurte et al., Cell 43:551-558, 1985). The present study demonstrates that freshly ovulated rat oocytes released their tPA into the surrounding medium upon in vitro activation by sperm penetration or treatment with a calcium ionophore. The presence of a neutralizing monoclonal anti-tPA antibody during in vitro activation by the calcium ionophore inhibited the activation-induced zona hardening and also preserved the ability of the oocyte to be penetrated by sperm subsequent to activation. Rat oocytes undergo zona hardening during in vitro maturation in the absence of serum, presumably as a result of spontaneous cortical granule release, based on findings in mice and hamsters. In the present study, the anti-tPA antibody prevented the zona hardening and enhanced partition by
spermatozoa
of rat oocytes that were matured in vitro without serum. Collectively, the observations reported have suggest a possible role of tPA released during the cortical granule reaction in the zona reaction, which contributes to the block to polyspermy.
...
PMID:Release of tissue-type plasminogen activator by activated rat eggs and its possible role in the zona reaction. 151 47
After a single injection of serum gonadotrophin (PMSG) at the dose of 15 IU/kg, i.m. into rams testosterone in the plasma of blood showed a significant rise between 4th and 7th day post-injection. At the same time (4th-7th day) the
plasminogen activator
activity (PAA) in seminal plasma was found to be increased, but the
plasminogen activator
inhibition (PAI) expressed against
t-PA
(anti-t-PA) showed an increase between 32nd and 46th day. In
spermatozoa
a marked increase of PAA was revealed between 32nd and 46th day post-injection, while an increase of PAI (anti-t-PA) was exhibited on the 74th day. Plasmin inhibition (PI) in seminal plasma and
spermatozoa
showed no change compared to controls. A positive correlation has been found between increased concentrations of testosterone and PAA or PAI (anti-t-PA) in
spermatozoa
and seminal plasma. The induced increase of PAA in
spermatozoa
under the effect of testosterone might be of physiological importance, since PAA is localized to sperm membranes and might participate in the whole process of fertilization.
...
PMID:Increased plasminogen activator activity and plasminogen activator inhibition in spermatozoa and seminal plasma of the ram after serum gonadotrophin (PMSG) administration. Correlation with the increased level of testosterone in the blood. 177 40
The objective of this investigation was to evaluate histologically and pathologically the effect of long-term sustained release of D and DHT on the reproductive system of male rats. A total of 120 Sprague-Dawley male albino rats were distributed equally into three groups. Two CDD, one nonimpregnated and the other impregnated with
PLA
, were implanted in each rat in groups I and II. Capsules implanted in group I rats were loaded with 20 mg DHT and 20 mg D each. Group II rats were implanted with two empty capsules (sham group), and group III animals served as unimplanted controls. Blood samples were withdrawn weekly via tail artery from all animals. Eight rats from each group were euthanized at the end of the one, three, six, nine, and twelve months following the implantation of the devices. No significant changes in the weights of vital (spleen, kidneys, heart, adrenals, lungs) organs of rats were observed among any of the three different groups. Vas deferens and epididymal fluid were devoid of normal
spermatozoa
within three months of implanting the D+DHT containing devices. Testes weights decreased significantly in the rats implanted with CDD containing D+DHT and the seminiferous tubules became oligospermic after one month and azoospermic after three months.(ABSTRACT TRUNCATED AT 250 WORDS)
...
PMID:Pathophysiological evaluation associated with sustained delivery of danazol and dihydrotestosterone in adult male rodents. 794 36
Mature
spermatozoa
contain a number of proteases that are supposed to contribute to their fertilizing ability. The present study was directed at
plasminogen activator
(PA), a protease that belongs to the group of serine proteases and converts the zymogen plasminogen to the active broad-spectrum protease plasmin. To investigate the possible role of PA in the fertilization process, we have measured sperm-bound PA activity in 63 patients included in an in-vitro fertilization (IVF) programme and assessed their relationship to standard semen parameters and the rate of fertilization. PA activity was correlated significantly with the sperm count, as well as with sperm motility and morphology. Using logistic regression analysis, specific PA (pmol pNA 10(-6) cells min-2) was found to significantly influence the probability of fertilization. Other significantly predictive factors were motility and the percentage of
spermatozoa
with normal morphology. The sperm concentration (10(6) cells ml-1) did not significantly affect the outcome of IVF. We suggest that sperm-bound PA is involved in the fertilization process and may represent a potential indicator of sperm fertilizing capacity.
...
PMID:Plasminogen activator activity and fertilizing ability of human spermatozoa. 835 35
At the time of fertilization both murine gametes express plasminogen-dependent proteolytic activity: unfertilized eggs secrete
tissue-type plasminogen activator
and ejaculated
spermatozoa
have urokinase-type plasminogen activator bound to their surface. We now report that plasminogen is present in the fertilization environment and that both
spermatozoa
and eggs are able to specifically bind plasminogen. Furthermore, in vitro fertilization of mouse eggs is inhibited by antibodies which inhibit the catalytic activity of plasmin. Finally, with two different in vitro fertilization protocols, the addition of plasminogen to the fertilization medium increases the yield of fertilized eggs. These results provide evidence for a role of the
plasminogen activator
/plasmin proteolytic cascade in mammalian fertilization.
...
PMID:Involvement of the plasminogen activator/plasmin proteolytic cascade in fertilization. 838 18
Plasminogen activator activity (PAA) and
plasminogen activator
inhibition (PAI), against
t-PA
(t-PAI) or u-PA (u-PAI), in
spermatozoa
and seminal plasma as well as testosterone in the blood of Friesland, Chios, and Karagouniki rams all showed a seasonal variation with the highest values during the corresponding breeding season of the ewes (Autumn-Winter). The seasonal variation of PAA and PAI in
spermatozoa
or seminal plasma as well as blood testosterone was different among the three breeds studied. Increased spermatozoal PAA was observed in November and May in Friesland rams, in October and November in Chios rams, and in October in Karagouniki rams. Spermatozoal t-PAI was increased in December and June in Friesland rams, in November and December in Chios rams, and in November in Karagouniki rams. Spermatozoal u-PAI was increased in December in Friesland rams, in October and December in Chios rams, and in November and December in Karagouniki rams. Plasminogen activator activity and PAI in seminal plasma also showed similar seasonal variations. Plasminogen activator activity and PAI in
spermatozoa
and seminal plasma showed a positive correlation with blood testosterone. The results of the present study support our previous findings on the possible role of spermatozoal PAA and PAI in the fertilizing ability of
spermatozoa
.
...
PMID:Breed and seasonal variation of plasminogen activator activity and plasminogen activator inhibition in spermatozoa and seminal plasma of the ram in correlation with testosterone in the blood. 846 94
The objective of this study was to evaluate the effect of alpha-tocopherol on blood testosterone and specific proteolytic enzymes in
spermatozoa
and seminal plasma, with final aim the increase of sperm fertilizing ability with a nutritional supplement. The effect of alpha-tocopherol supplementation on testosterone parameters (mean value, basal level, peak number, mean concentration value during peaks, peak amplitude, peak duration) and
plasminogen activator
activity (PAA),
plasminogen activator
inhibition (PAI) and plasmin inhibition (PI) of
spermatozoa
and seminal plasma was studied in the ram during autumn (estrous period for the sheep in Greece) and spring (anestrous period). Treated animals showed a marked increase in serum alpha-tocopherol. Testosterone parameters were not affected by the alpha-tocopherol in either autumn or spring, however, the spermatozoal PAA and PAI (anti-tPA) were increased in the spring but not in autumn. These enzymes and their inhibitors are normally increased in autumn (the breeding season) and low in spring. If PAA can improve the fertilizing ability of
spermatozoa
in the spring, our finding may mean that a nutritional supplement, such as alpha-tocopherol, could provide rams for an accelerated onset of the breeding season in the ewe.
...
PMID:Effect of alpha-tocopherol on plasma testosterone and plasminogen activator activity or inhibition in ram spermatozoa. 1073 41
The effect of tannic acid, a common flavonoid, on the acrosin and
plasminogen activator
activity and plasmin activity of human and ram
spermatozoa
was evaluated. Acrosin and
plasminogen activator
activity were determined by spectrophotometry using the chromogenic substrates N-alpha-benzoyl-DL-arginine para-nitroanilide-HCl (BAPNA) and H-D-valyl-L-leucyl-L-lysine-p-nitroanilide-2HCl (S-2251), respectively. In extracts from both human and ovine acrosomes, the activities of acrosin and plasminogen activators were susceptible to tannic acid inhibition. The inhibitory effect of tannic acid was observed at concentrations > 50 micromol l(-1) in a dose-dependent manner. In additional experiments, low concentrations of tannic acid significantly inhibited
tissue-type plasminogen activator
, urokinase-type plasminogen activator and plasmin activity in a concentration-dependent manner over the range 0.25-200 micromol l(-1). Tannic acid reduced the motility of ram
spermatozoa
at a concentration of 1000 micromol l(-1) after 2 and 3 h co-incubation with
spermatozoa
. The motility of human
spermatozoa
remained unchanged over the range 0.1-1000 micromol tannic acid l(-1) during 3 h co-incubation. These results indicate that tannic acid inhibited the activity of both acrosin and
plasminogen activator
and indicates a possible mechanism by which flavonoids exert their antifertility effects.
...
PMID:Inhibition of human and ovine acrosomal enzymes by tannic acid in vitro. 1122 36
1
2
3
Next >>